Institutional investors purchased a net $1.3 million shares of ALIM during the quarter ended September 2015 and now own 54.66% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 1.3 Million shares of Alimera Sciences Inc